Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4798682
Max Phase: Preclinical
Molecular Formula: C28H29ClN4O4S
Molecular Weight: 553.08
Molecule Type: Unknown
Associated Items:
ID: ALA4798682
Max Phase: Preclinical
Molecular Formula: C28H29ClN4O4S
Molecular Weight: 553.08
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CC(=O)N1CCC2(CC1)c1cc(C(=O)NCc3ccccc3Cl)ccc1N(S(=O)(=O)c1cccnc1)C2C
Standard InChI: InChI=1S/C28H29ClN4O4S/c1-19-28(11-14-32(15-12-28)20(2)34)24-16-21(27(35)31-17-22-6-3-4-8-25(22)29)9-10-26(24)33(19)38(36,37)23-7-5-13-30-18-23/h3-10,13,16,18-19H,11-12,14-15,17H2,1-2H3,(H,31,35)
Standard InChI Key: ADIMLYDNRFSNCC-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 553.08 | Molecular Weight (Monoisotopic): 552.1598 | AlogP: 4.14 | #Rotatable Bonds: 5 |
Polar Surface Area: 99.68 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 8 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: | CX Basic pKa: 1.07 | CX LogP: 2.54 | CX LogD: 2.54 |
Aromatic Rings: 3 | Heavy Atoms: 38 | QED Weighted: 0.51 | Np Likeness Score: -1.36 |
1. Panknin O,Wagenfeld A,Bone W,Bender E,Nowak-Reppel K,Fernández-Montalván AE,Nubbemeyer R,Bäurle S,Ring S,Schmees N,Prien O,Schäfer M,Friedrich C,Zollner TM,Steinmeyer A,Mueller T,Langer G. (2020) Discovery and Characterization of BAY 1214784, an Orally Available Spiroindoline Derivative Acting as a Potent and Selective Antagonist of the Human Gonadotropin-Releasing Hormone Receptor as Proven in a First-In-Human Study in Postmenopausal Women., 63 (20): [PMID:32960053] [10.1021/acs.jmedchem.0c01076] |
Source(1):